Ionis upgraded at BMO on Tryngolza adoption for severe hypertriglyceridemia

BMO upgrades Ionis to Outperform, raising PT to $66 on rapid Tryngolza uptake and $3B+ peak sales vs Arrowhead.

CryptoAlerta — análise de criptomoedas e mercado em tempo real